Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB1214: Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.

signed by governor

<b>Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.</b> Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies.

Official bill page · Source: Richmond Sunlight

Ask about HB1214

Full bill text

Version CHAP0752 · 2026-04-13

Full text

Changes in this version: added text deleted text

An Act to amend and reenact §§ 38.2-3407.15:5 and 38.2-3418.10 of the Code of Virginia, relating to health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.

Be it enacted by the General Assembly of Virginia:

1. That §§ 38.2-3407.15:5 and 38.2-3418.10 of the Code of Virginia are amended and reenacted as follows:

§ 38.2-3407.15:5. Limit on cost-sharing payments for prescription insulin drugs.

A. As used in this section:

"Carrier" has the same meaning ascribed thereto in subsection A of § 38.2-3407.15.

"Cost-sharing payment" means the total amount a covered person is required to pay at the point of sale in order to receive a prescription drug that is covered under the covered person's health plan.

"Covered person" means a policyholder, subscriber, participant, or other individual covered by a health plan.

"Health plan" means any health benefit plan, as defined in § 38.2-3438, that provides coverage for a prescription insulin drug.

"Pharmacy benefits manager" means an entity that engages in the administration or management of prescription drug benefits provided by a carrier for the benefit of its covered persons.

"Prescription insulin drug" means a prescription drug that contains insulin and is used to treat diabetes.

"Provider contract" has the same meaning ascribed thereto in subsection A of § 38.2-3407.15.

B. Every health plan offered by a carrier shall set the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug at an amount that does not exceed $50 $35 in aggregate, including situations where the covered person is prescribed more than one insulin drug, per 30-day supply of the prescription insulin drug, regardless of the amount or type of insulin needed to fill the covered person's prescription.

C. Nothing in this section shall prevent a carrier from setting a covered person's cost-sharing payment for a covered prescription insulin drug at an amount that is less than the maximum amount permitted pursuant to subsection B.

D. No provider contract between a carrier or its pharmacy benefits manager and a pharmacy or its contracting agent shall contain a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds the amount of the cost-sharing payment for the covered prescription insulin drug established by the carrier pursuant to subsection B.

E. This section shall apply with respect to health plans and provider contracts entered into, amended, extended, or renewed on or after January 1, 2021.

F. Pursuant to the authority granted by § 38.2-223, the Commission may adopt such rules and regulations as it may deem necessary to implement this section.

§ 38.2-3418.10. Coverage for diabetes.

A. As used in this section:

"Cost-sharing payment" means the total amount a covered person is required to pay at the point of sale in order to receive equipment and supplies that are covered under the covered person's policy, contract, or plan.

"Equipment and supplies" means blood glucose meters and strips, urine-testing strips, syringes, continuous glucose monitors and supplies, and insulin pump supplies. "Equipment and supplies" shall not be considered durable medical equipment.

B. Each insurer proposing to issue an individual or group hospital policy or major medical policy in this Commonwealth, each corporation proposing to issue an individual or group hospital, medical or major medical subscription contract, and each health maintenance organization providing a health care plan for health care services shall provide coverage for diabetes as provided in this section.

B. C. Such coverage shall include benefits for equipment, and supplies and in-person outpatient self-management training and education, including medical nutrition therapy, for the treatment of insulin-dependent diabetes, insulin-using diabetes, gestational diabetes, and noninsulin-using diabetes if prescribed by a health care professional legally authorized to prescribe such items under law. As used herein, the terms "equipment" and "supplies" shall not be considered durable medical equipment.

C. D. To qualify for coverage under this section, diabetes in-person outpatient self-management training and education shall be provided by a certified, registered or licensed health care professional. A managed care health insurance plan, as defined in Chapter 58 (§ 38.2-5800 et seq.) of this title, may require such health care professional to be a member of the plan's provider network; provided that such network includes sufficient health care professionals who are qualified by specific education, experience, and credentials to provide the covered benefits described in this section.

D. E. No insurer, corporation, or health maintenance organization shall impose upon any person receiving benefits pursuant to this section any copayment, fee, or condition that is not equally imposed upon all individuals in the same benefit category, nor shall any insurer, corporation, or health maintenance organization impose any policy-year or calendar-year dollar or durational benefit limitations or maximums for benefits or services provided under this section. Additionally, every policy, contract, or plan offered by an insurer, corporation, or health maintenance organization shall set the cost-sharing payment that a covered person is required to pay for equipment and supplies at an amount that does not exceed $35 in aggregate, including situations where the covered person is prescribed more than one piece of equipment or type of supplies, per 30-day supply of the equipment and supplies, regardless of the amount or type of equipment or supplies needed to fill the covered person's prescription.

E. F. The requirements of this section shall apply to all insurance policies, contracts and plans delivered, issued for delivery, reissued, or extended on and after July 1, 2000, or at any time thereafter when any term of the policy, contract or plan is changed or any premium adjustment is made.

F. G. This section shall not apply to short-term travel, accident only, or limited or specified disease policies or contracts, nor to policies or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans.

2. That the provisions of this act shall apply to insurance policies, contracts, and plans delivered, issued for delivery, reissued, amended, or extended on or after January 1, 2027.

3. That, to the extent that the health benefit for diabetes equipment and supplies or any portion thereof described in § 38.2-3418.10 of the Code of Virginia, as amended by this act, is included in the Commonwealth's current essential health benefits benchmark plan, as defined in § 30-343.1 of the Code of Virginia, the mandate to provide coverage of such benefit or portion shall not apply to the individual and small group markets. However, the provisions of this enactment clause shall not apply to subdivision E of § 38.2-3418.10 of the Code of Virginia, as amended by this act.

Legislative actions

2026-03-31 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

2026-03-11 · history

Reconsideration of Senate passage agreed to by Senate Block Vote (40-Y 0-N 0-A)

2026-02-12 · history

Constitutional reading dispensed (on 1st reading)

2026-02-05 · history

Reported from Labor and Commerce (22-Y 0-N)

2026-03-30 · history

Signed by President

2026-03-11 · history

Engrossed by Senate as amended

2026-03-11 · history

Committee amendment agreed to (Voice Vote)

2026-03-09 · history

Senate committee offered

2026-03-09 · history

Reported from Commerce and Labor with amendment (15-Y 0-N)

2026-01-27 · history

Assigned HCL sub: Subcommittee #1

2026-03-11 · history

Passed Senate with amendment Block Vote (39-Y 0-N 0-A)

2026-02-03 · history

Subcommittee recommends reporting

2026-03-09 · history

Reported from Commerce and Labor with amendment

2026-03-30 · history

Bill text as passed House and Senate (HB1214ER)

2026-03-10 · history

Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A)

2026-02-10 · history

Read second time and engrossed

2026-02-17 · history

Fiscal Impact Statement from State Corporation Commission (HB1214)

2026-03-10 · history

Passed by for the day Block Vote (Voice Vote)

2026-03-11 · history

Commerce and Labor Amendment agreed to

2026-03-11 · history

Read third time

2026-02-11 · history

Reconsideration of passage agreed to by House

2026-02-09 · history

Read first time

2026-03-11 · history

Passed Senate with amendment

2026-02-05 · history

Reported from Labor and Commerce

2026-04-13 · history

Fiscal Impact Statement from State Corporation Commission (HB1214)

2026-03-11 · history

Passed Senate with amendment Block Vote (39-Y 0-N 0-A)

2026-02-11 · history

Passed House Block Vote (98-Y 0-N 0-A)

2026-02-11 · history

Passed House Block Vote (98-Y 0-N 0-A)

2026-03-11 · history

Passed Senate Block Vote (39-Y 0-N 0-A)

2026-03-12 · history

Senate amendment agreed to by House (97-Y 0-N 0-A)

2026-02-11 · history

Reconsideration of passage agreed to by House

2026-03-11 · history

Reconsideration of Block Vote (40-Y 0-N 0-A)

2026-04-13 · history

Approved by Governor-Chapter 752 (effective 7/1/2026)

2026-03-10 · history

Rules suspended

2026-03-10 · history

Passed by for the day

2026-02-11 · history

Read third time and passed House Block Vote (96-Y 0-N 0-A)

2026-03-11 · history

Passed Senate with amendment Block Vote (40-Y 0-N 0-A)

2026-03-31 · history

Signed by Speaker

2026-01-14 · history

Prefiled and ordered printed; Offered 01-14-2026 26101381D

2026-04-13 · history

Acts of Assembly Chapter text (CHAP0752)

2026-02-11 · history

Read third time and passed House Block Vote (96-Y 0-N 0-A)

2026-03-31 · history

Enrolled Bill communicated to Governor on March 31, 2026

2026-01-14 · history

Referred to Committee on Labor and Commerce

2026-03-30 · history

Enrolled

2026-03-11 · history

Passed Senate Block Vote (40-Y 0-N 0-A)

2026-02-12 · history

Referred to Committee on Commerce and Labor

2026-02-03 · history

Subcommittee recommends reporting (9-Y 0-N)

Raw source record
{
    "id": 85117,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb1214\/",
    "tags": {
        "149737": "health insurance",
        "149738": "diabetes",
        "149739": "cost sharing",
        "149740": "medicine",
        "149741": "regulation"
    },
    "text": [
        {
            "date": "2026-01-14",
            "number": "HB1214",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb1214.pdf"
        },
        {
            "date": "2026-03-30",
            "number": "HB1214ER"
        },
        {
            "date": "2026-04-13",
            "number": "CHAP0752"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb1214",
    "patron": "Delaney, Karrie",
    "status": "signed by governor",
    "chamber": "house",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 84573,
            "name": "Appropriations",
            "year": 2026,
            "count": 3,
            "number": "hb736",
            "status": "signed by governor",
            "catch_line": "Health insurance; required provisions regarding prior authorization for prescription drugs.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 84310,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb481",
            "status": "signed by governor",
            "catch_line": "Prior authorization; requiring physician review for denial.",
            "date_introduced": "January 12, 2026"
        },
        {
            "id": 84319,
            "name": "Appropriations",
            "year": 2026,
            "count": 3,
            "number": "hb490",
            "status": "signed by governor",
            "catch_line": "Health insurance; coverage for early refills of prescription eye drops.",
            "date_introduced": "January 12, 2026"
        },
        {
            "id": 85291,
            "name": null,
            "year": 2026,
            "count": 2,
            "number": "hb1318",
            "status": "signed by governor",
            "catch_line": "Hospitals; emergency department physicians.",
            "date_introduced": "January 16, 2026"
        },
        {
            "id": 85549,
            "name": "Education and Health",
            "year": 2026,
            "count": 2,
            "number": "sb545",
            "status": "failed committee",
            "catch_line": "Ivermectin; authorize over-the-counter sale.",
            "date_introduced": "January 14, 2026"
        }
    ],
    "summary": "<b>Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.<\/b> Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies.",
    "version": "CHAP0752",
    "copatron": [
        {
            "shortname": "rahenson",
            "partisanship": 13,
            "name_formatted": "Del. Rozia Henson (D-Woodbridge)"
        },
        {
            "shortname": "aymcclure",
            "partisanship": 11,
            "name_formatted": "Del. Adele McClure (D-Arlington)"
        },
        {
            "shortname": "msprice",
            "partisanship": 19,
            "name_formatted": "Del. Cia Price (D-Newport News)"
        },
        {
            "shortname": "kkltran",
            "partisanship": 17,
            "name_formatted": "Del. Kathy Tran (D-Springfield)"
        },
        {
            "shortname": "ebbennett-parker",
            "partisanship": 13,
            "name_formatted": "Sen. Elizabeth Bennett-Parker (D-Alexandria)"
        }
    ],
    "committee": "Commerce and Labor",
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a> of the Code of Virginia, relating to health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a>. Limit on cost-sharing payments for prescription insulin drugs.<\/p><p class=\"section\">A. As used in this section:<\/p><p class=\"section\">\"Carrier\" has the same meaning ascribed thereto in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Cost-sharing payment\" means the total amount a covered person is required to pay at the point of sale in order to receive a prescription drug that is covered under the covered person's health plan.<\/p><p class=\"section\">\"Covered person\" means a policyholder, subscriber, participant, or other individual covered by a health plan.<\/p><p class=\"section\">\"Health plan\" means any health benefit plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3438\/'>38.2-3438<\/a>, that provides coverage for a prescription insulin drug.<\/p><p class=\"section\">\"Pharmacy benefits manager\" means an entity that engages in the administration or management of prescription drug benefits provided by a carrier for the benefit of its covered persons.<\/p><p class=\"section\">\"Prescription insulin drug\" means a prescription drug that contains insulin and is used to treat diabetes.<\/p><p class=\"section\">\"Provider contract\" has the same meaning ascribed thereto in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">B. Every health plan offered by a carrier shall set the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug at an amount that does not exceed<s> $50<\/s><em class=\"new\"> $35 in aggregate, including situations where the covered person is prescribed more than one insulin drug,<\/ins> per 30-day supply of the prescription insulin drug, regardless of the amount or type of insulin needed to fill the covered person's prescription.<\/p><p class=\"section\">C. Nothing in this section shall prevent a carrier from setting a covered person's cost-sharing payment for a covered prescription insulin drug at an amount that is less than the maximum amount permitted pursuant to subsection B.<\/p><p class=\"section\">D. No provider contract between a carrier or its pharmacy benefits manager and a pharmacy or its contracting agent shall contain a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds the amount of the cost-sharing payment for the covered prescription insulin drug established by the carrier pursuant to subsection B.<\/p><p class=\"section\">E. This section shall apply with respect to health plans and provider contracts entered into, amended, extended, or renewed on or after January 1, 2021.<\/p><p class=\"section\">F. Pursuant to the authority granted by \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-223\/'>38.2-223<\/a>, the Commission may adopt such rules and regulations as it may deem necessary to implement this section.<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>. Coverage for diabetes.<\/p><p class=\"section\">A. <em class=\"new\">As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Cost-sharing payment\" means the total amount a covered person is required to pay at the point of sale in order to receive equipment and supplies that are covered under the covered person's policy, contract, or plan.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Equipment and supplies\" means blood glucose meters and strips, urine-testing strips, syringes, continuous glucose monitors and supplies, and insulin pump supplies. \"Equipment and supplies\" shall not be considered durable medical equipment.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. <\/ins>Each insurer proposing to issue an individual or group hospital policy or major medical policy in this Commonwealth, each corporation proposing to issue an individual or group hospital, medical or major medical subscription contract, and each health maintenance organization providing a health care plan for health care services shall provide coverage for diabetes as provided in this section.<\/p><p class=\"section\"><s>B. <\/s><em class=\"new\">C. <\/ins>Such coverage shall include benefits for equipment<s>,<\/s><em class=\"new\"> and<\/ins> supplies and in-person outpatient self-management training and education, including medical nutrition therapy, for the treatment of insulin-dependent diabetes, insulin-using diabetes, gestational diabetes<em class=\"new\">,<\/ins> and noninsulin-using diabetes if prescribed by a health care professional legally authorized to prescribe such items under law.<s> As used herein, the terms \"equipment\" and \"supplies\" shall not be considered durable medical equipment.<\/s><\/p><p class=\"section\"><s>C. <\/s><em class=\"new\">D. <\/ins>To qualify for coverage under this section, diabetes in-person outpatient self-management training and education shall be provided by a certified, registered or licensed health care professional. A managed care health insurance plan, as defined in Chapter 58 (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-5800\/'>38.2-5800<\/a> et seq.) of this title, may require such health care professional to be a member of the plan's provider network; provided that such network includes sufficient health care professionals who are qualified by specific education, experience, and credentials to provide the covered benefits described in this section.<\/p><p class=\"section\"><s>D. <\/s><em class=\"new\">E. <\/ins>No insurer, corporation, or health maintenance organization shall impose upon any person receiving benefits pursuant to this section any copayment, fee<em class=\"new\">,<\/ins> or condition that is not equally imposed upon all individuals in the same benefit category, nor shall any insurer, corporation<em class=\"new\">,<\/ins> or health maintenance organization impose any policy-year or calendar-year dollar or durational benefit limitations or maximums for benefits or services provided under this section.<em class=\"new\"> Additionally, every policy, contract, or plan offered by an insurer, corporation, or health maintenance organization shall set the cost-sharing payment that a covered person is required to pay for equipment and supplies at an amount that does not exceed $35 in aggregate, including situations where the covered person is prescribed more than one piece of equipment or type of supplies, per 30-day supply of the equipment and supplies, regardless of the amount or type of equipment or supplies needed to fill the covered person's prescription.<\/ins><\/p><p class=\"section\"><s>E. <\/s><em class=\"new\">F. <\/ins>The requirements of this section shall apply to all insurance policies, contracts and plans delivered, issued for delivery, reissued, or extended on and after July 1, 2000, or at any time thereafter when any term of the policy, contract or plan is changed or any premium adjustment is made.<\/p><p class=\"section\"><s>F. <\/s><em class=\"new\">G. <\/ins>This section shall not apply to short-term travel, accident only, or limited or specified disease policies or contracts, nor to policies or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to insurance policies, contracts, and plans delivered, issued for delivery, reissued, amended, or extended on or after January 1, 2027.<\/p><p class=\"enactcls\">3. That, to the extent that the health benefit for diabetes equipment and supplies or any portion thereof described in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>\u00a0of the Code of Virginia, as amended by this act, is included in the Commonwealth's current essential health benefits benchmark plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/30-343.1\/'>30-343.1<\/a>\u00a0of the Code of Virginia, the mandate to provide coverage of such benefit or portion shall not apply to the individual and small group markets. However, the provisions of this enactment clause shall not apply to subdivision E of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>\u00a0of the Code of Virginia, as amended by this act.<\/p>",
    "catch_line": "Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 1454,
    "patron_party": "D",
    "patron_place": "Centreville",
    "summary_hash": "7e4099560cbc3148ee37b6a5b75638dc",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Centreville)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "5932de7e912f720fcb277ea0d87b839316985462300106907141dbe977baae1d",
            "code": "CHAP0752",
            "bill_id": 85117,
            "source_url": null,
            "source_date": "2026-04-13",
            "source_hash": "f6f6251715b84aa91383adc4234c77fc760c3ba6ac19ad5f329296af37445fb8",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a> of the Code of Virginia, relating to health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:5\/'>38.2-3407.15:5<\/a>. Limit on cost-sharing payments for prescription insulin drugs.<\/p><p class=\"section\">A. As used in this section:<\/p><p class=\"section\">\"Carrier\" has the same meaning ascribed thereto in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Cost-sharing payment\" means the total amount a covered person is required to pay at the point of sale in order to receive a prescription drug that is covered under the covered person's health plan.<\/p><p class=\"section\">\"Covered person\" means a policyholder, subscriber, participant, or other individual covered by a health plan.<\/p><p class=\"section\">\"Health plan\" means any health benefit plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3438\/'>38.2-3438<\/a>, that provides coverage for a prescription insulin drug.<\/p><p class=\"section\">\"Pharmacy benefits manager\" means an entity that engages in the administration or management of prescription drug benefits provided by a carrier for the benefit of its covered persons.<\/p><p class=\"section\">\"Prescription insulin drug\" means a prescription drug that contains insulin and is used to treat diabetes.<\/p><p class=\"section\">\"Provider contract\" has the same meaning ascribed thereto in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">B. Every health plan offered by a carrier shall set the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug at an amount that does not exceed<s> $50<\/s><em class=\"new\"> $35 in aggregate, including situations where the covered person is prescribed more than one insulin drug,<\/ins> per 30-day supply of the prescription insulin drug, regardless of the amount or type of insulin needed to fill the covered person's prescription.<\/p><p class=\"section\">C. Nothing in this section shall prevent a carrier from setting a covered person's cost-sharing payment for a covered prescription insulin drug at an amount that is less than the maximum amount permitted pursuant to subsection B.<\/p><p class=\"section\">D. No provider contract between a carrier or its pharmacy benefits manager and a pharmacy or its contracting agent shall contain a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds the amount of the cost-sharing payment for the covered prescription insulin drug established by the carrier pursuant to subsection B.<\/p><p class=\"section\">E. This section shall apply with respect to health plans and provider contracts entered into, amended, extended, or renewed on or after January 1, 2021.<\/p><p class=\"section\">F. Pursuant to the authority granted by \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-223\/'>38.2-223<\/a>, the Commission may adopt such rules and regulations as it may deem necessary to implement this section.<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>. Coverage for diabetes.<\/p><p class=\"section\">A. <em class=\"new\">As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Cost-sharing payment\" means the total amount a covered person is required to pay at the point of sale in order to receive equipment and supplies that are covered under the covered person's policy, contract, or plan.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Equipment and supplies\" means blood glucose meters and strips, urine-testing strips, syringes, continuous glucose monitors and supplies, and insulin pump supplies. \"Equipment and supplies\" shall not be considered durable medical equipment.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. <\/ins>Each insurer proposing to issue an individual or group hospital policy or major medical policy in this Commonwealth, each corporation proposing to issue an individual or group hospital, medical or major medical subscription contract, and each health maintenance organization providing a health care plan for health care services shall provide coverage for diabetes as provided in this section.<\/p><p class=\"section\"><s>B. <\/s><em class=\"new\">C. <\/ins>Such coverage shall include benefits for equipment<s>,<\/s><em class=\"new\"> and<\/ins> supplies and in-person outpatient self-management training and education, including medical nutrition therapy, for the treatment of insulin-dependent diabetes, insulin-using diabetes, gestational diabetes<em class=\"new\">,<\/ins> and noninsulin-using diabetes if prescribed by a health care professional legally authorized to prescribe such items under law.<s> As used herein, the terms \"equipment\" and \"supplies\" shall not be considered durable medical equipment.<\/s><\/p><p class=\"section\"><s>C. <\/s><em class=\"new\">D. <\/ins>To qualify for coverage under this section, diabetes in-person outpatient self-management training and education shall be provided by a certified, registered or licensed health care professional. A managed care health insurance plan, as defined in Chapter 58 (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-5800\/'>38.2-5800<\/a> et seq.) of this title, may require such health care professional to be a member of the plan's provider network; provided that such network includes sufficient health care professionals who are qualified by specific education, experience, and credentials to provide the covered benefits described in this section.<\/p><p class=\"section\"><s>D. <\/s><em class=\"new\">E. <\/ins>No insurer, corporation, or health maintenance organization shall impose upon any person receiving benefits pursuant to this section any copayment, fee<em class=\"new\">,<\/ins> or condition that is not equally imposed upon all individuals in the same benefit category, nor shall any insurer, corporation<em class=\"new\">,<\/ins> or health maintenance organization impose any policy-year or calendar-year dollar or durational benefit limitations or maximums for benefits or services provided under this section.<em class=\"new\"> Additionally, every policy, contract, or plan offered by an insurer, corporation, or health maintenance organization shall set the cost-sharing payment that a covered person is required to pay for equipment and supplies at an amount that does not exceed $35 in aggregate, including situations where the covered person is prescribed more than one piece of equipment or type of supplies, per 30-day supply of the equipment and supplies, regardless of the amount or type of equipment or supplies needed to fill the covered person's prescription.<\/ins><\/p><p class=\"section\"><s>E. <\/s><em class=\"new\">F. <\/ins>The requirements of this section shall apply to all insurance policies, contracts and plans delivered, issued for delivery, reissued, or extended on and after July 1, 2000, or at any time thereafter when any term of the policy, contract or plan is changed or any premium adjustment is made.<\/p><p class=\"section\"><s>F. <\/s><em class=\"new\">G. <\/ins>This section shall not apply to short-term travel, accident only, or limited or specified disease policies or contracts, nor to policies or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to insurance policies, contracts, and plans delivered, issued for delivery, reissued, amended, or extended on or after January 1, 2027.<\/p><p class=\"enactcls\">3. That, to the extent that the health benefit for diabetes equipment and supplies or any portion thereof described in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>\u00a0of the Code of Virginia, as amended by this act, is included in the Commonwealth's current essential health benefits benchmark plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/30-343.1\/'>30-343.1<\/a>\u00a0of the Code of Virginia, the mandate to provide coverage of such benefit or portion shall not apply to the individual and small group markets. However, the provisions of this enactment clause shall not apply to subdivision E of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3418.10\/'>38.2-3418.10<\/a>\u00a0of the Code of Virginia, as amended by this act.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-13",
                    "number": "CHAP0752"
                }
            }
        }
    ],
    "copatron_count": 5,
    "patron_address": [
        "P.O. Box 231023",
        "Centreville",
        "VA 20120"
    ],
    "patron_chamber": "house",
    "patron_started": 2018,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/13\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0752)",
            "date_raw": "2026-04-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/13\/2026",
            "status": "Approved by Governor-Chapter 752 (effective 7\/1\/2026)",
            "date_raw": "2026-04-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "04\/13\/2026",
            "status": "Fiscal Impact Statement from State Corporation Commission (HB1214)",
            "date_raw": "2026-04-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Enrolled Bill communicated to Governor on March 31, 2026",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/30\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/30\/2026",
            "status": "Bill text as passed House and Senate (HB1214ER)",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/30\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Senate amendment agreed to by House (97-Y 0-N 0-A)",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": "301898",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with amendment",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with amendment  Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Commerce and Labor Amendment agreed to",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301587",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with amendment Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301596",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Reconsideration of Senate passage agreed to by Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301595",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with amendment Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301596",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Reconsideration of   Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301595",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate  Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Engrossed by Senate as amended",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Committee amendment agreed to (Voice Vote)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301587",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": "301569",
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 2nd reading) (37-Y 0-N 0-A)",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": "301568",
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Reported from Commerce and Labor with amendment (15-Y 0-N)",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": "301218",
            "translation": "passed committee"
        },
        {
            "date": "03\/09\/2026",
            "status": "Reported from Commerce and Labor with amendment",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": "301218",
            "translation": "passed committee"
        },
        {
            "date": "03\/09\/2026",
            "status": "Senate committee offered",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/17\/2026",
            "status": "Fiscal Impact Statement from State Corporation Commission (HB1214)",
            "date_raw": "2026-02-17",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Referred to Committee on Commerce and Labor",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/12\/2026",
            "status": "Constitutional reading dispensed (on 1st reading)",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/11\/2026",
            "status": "Passed House  Block Vote (98-Y 0-N 0-A)",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": "296298",
            "translation": "passed house"
        },
        {
            "date": "02\/11\/2026",
            "status": "Reconsideration of passage agreed to by House",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/11\/2026",
            "status": "Read third time and passed House  Block Vote (96-Y 0-N 0-A)",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": "296296",
            "translation": "passed house"
        },
        {
            "date": "02\/11\/2026",
            "status": "Reconsideration of passage agreed to by House",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/11\/2026",
            "status": "Passed House  Block Vote (98-Y 0-N 0-A)",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed house"
        },
        {
            "date": "02\/11\/2026",
            "status": "Read third time and passed House  Block Vote (96-Y 0-N 0-A)",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed house"
        },
        {
            "date": "02\/10\/2026",
            "status": "Read second time and engrossed",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/09\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce (22-Y 0-N)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294905",
            "translation": "passed committee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting (9-Y 0-N)",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": "294217",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed subcommittee"
        },
        {
            "date": "01\/27\/2026",
            "status": "Assigned HCL sub: Subcommittee #1",
            "date_raw": "2026-01-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Referred to Committee on Labor and Commerce",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26101381D",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 424,
    "date_introduced": "2026-01-14",
    "patron_district": 9,
    "patron_shortname": "kkdelaney",
    "committee_chamber": "house",
    "status_detail_date": "04\/13\/2026",
    "committee_shortname": "commerce",
    "patron_name_formatted": "Del. Karrie Delaney (D-Centreville)"
}